Miljana Nenkov

8PUBLICATIONS
11CO-AUTHORS
Organic chemistry not elsewhere classifiedPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 13, 2025
Beyond Tumor Suppression: The Multifaceted Functions of HOPX in Tissue Differentiation, Metabolism, and Immunity.

Fabian Munzert, Miljana Nenkov, Alexander Berndt

|Aug 10, 2024
The Role of Adipocytes Recruited as Part of Tumor Microenvironment in Promoting Colorectal Cancer Metastases.

Yunxia Ma, Miljana Nenkov, Yuan Chen

|Mar 28, 2024
The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer.

Yunxia Ma, Miljana Nenkov, Alexander Berndt

|Jan 11, 2024
Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy.

Miljana Nenkov, Yihui Shi, Yunxia Ma

|Oct 14, 2022
Tumor-Intrinsic PD-L1 Exerts an Oncogenic Function through the Activation of the Wnt/β-Catenin Pathway in Human Non-Small Cell Lung Cancer.

Yunxia Ma, Rumyana Marinkova, Miljana Nenkov

|Nov 13, 2021
Fibulin 2 Is Hypermethylated and Suppresses Tumor Cell Proliferation through Inhibition of Cell Adhesion and Extracellular Matrix Genes in Non-Small Cell Lung Cancer.

Yunxia Ma, Miljana Nenkov, Desiree Charlotte Schröder

Pageof 2

Frequent Collaborators

8 joint publications

Yuan Chen

6 joint publications

Yunxia Ma

2 joint publications

Desiree Charlotte Schröder

2 joint publications

Otmar Huber